Kalbe Farma Pink Sheet Forward View

PTKFY Stock  USD 13.57  0.73  5.10%   
Kalbe Pink Sheet outlook is based on your current time horizon.
At this time the relative strength index (rsi) of Kalbe Farma's share price is below 20 indicating that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Kalbe Farma's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Kalbe Farma Tbk, which may create opportunities for some arbitrage if properly timed.
Using Kalbe Farma hype-based prediction, you can estimate the value of Kalbe Farma Tbk from the perspective of Kalbe Farma response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Kalbe Farma Tbk on the next trading day is expected to be 13.99 with a mean absolute deviation of 0.27 and the sum of the absolute errors of 16.77.

Kalbe Farma after-hype prediction price

    
  USD 13.57  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Historical Fundamental Analysis of Kalbe Farma to cross-verify your projections.

Kalbe Farma Additional Predictive Modules

Most predictive techniques to examine Kalbe price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kalbe using various technical indicators. When you analyze Kalbe charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A naive forecasting model for Kalbe Farma is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Kalbe Farma Tbk value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Kalbe Farma Naive Prediction Price Forecast For the 9th of February

Given 90 days horizon, the Naive Prediction forecasted value of Kalbe Farma Tbk on the next trading day is expected to be 13.99 with a mean absolute deviation of 0.27, mean absolute percentage error of 0.14, and the sum of the absolute errors of 16.77.
Please note that although there have been many attempts to predict Kalbe Pink Sheet prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Kalbe Farma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Kalbe Farma Pink Sheet Forecast Pattern

Backtest Kalbe Farma  Kalbe Farma Price Prediction  Research Analysis  

Kalbe Farma Forecasted Value

In the context of forecasting Kalbe Farma's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Kalbe Farma's downside and upside margins for the forecasting period are 10.45 and 17.53, respectively. We have considered Kalbe Farma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
13.57
13.99
Expected Value
17.53
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Kalbe Farma pink sheet data series using in forecasting. Note that when a statistical model is used to represent Kalbe Farma pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria116.1493
BiasArithmetic mean of the errors None
MADMean absolute deviation0.2749
MAPEMean absolute percentage error0.0197
SAESum of the absolute errors16.7708
This model is not at all useful as a medium-long range forecasting tool of Kalbe Farma Tbk. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Kalbe Farma. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Kalbe Farma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kalbe Farma Tbk. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
10.0313.5717.11
Details
Intrinsic
Valuation
LowRealHigh
8.2511.7915.33
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Kalbe Farma. Your research has to be compared to or analyzed against Kalbe Farma's peers to derive any actionable benefits. When done correctly, Kalbe Farma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Kalbe Farma Tbk.

Kalbe Farma After-Hype Price Density Analysis

As far as predicting the price of Kalbe Farma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kalbe Farma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Kalbe Farma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Kalbe Farma Estimiated After-Hype Price Volatility

In the context of predicting Kalbe Farma's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kalbe Farma's historical news coverage. Kalbe Farma's after-hype downside and upside margins for the prediction period are 10.03 and 17.11, respectively. We have considered Kalbe Farma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
13.57
13.57
After-hype Price
17.11
Upside
Kalbe Farma is somewhat reliable at this time. Analysis and calculation of next after-hype price of Kalbe Farma Tbk is based on 3 months time horizon.

Kalbe Farma Pink Sheet Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Kalbe Farma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kalbe Farma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kalbe Farma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.09 
3.54
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
13.57
13.57
0.00 
0.00  
Notes

Kalbe Farma Hype Timeline

Kalbe Farma Tbk is at this time traded for 13.57. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Kalbe is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.09%. %. The volatility of related hype on Kalbe Farma is about 118000.0%, with the expected price after the next announcement by competition of 13.57. The book value of the company was at this time reported as 4.2. The company last dividend was issued on the 3rd of June 2022. Kalbe Farma Tbk had 5:1 split on the 25th of October 2012. Assuming the 90 days horizon the next forecasted press release will be within a week.
Check out Historical Fundamental Analysis of Kalbe Farma to cross-verify your projections.

Kalbe Farma Related Hype Analysis

Having access to credible news sources related to Kalbe Farma's direct competition is more important than ever and may enhance your ability to predict Kalbe Farma's future price movements. Getting to know how Kalbe Farma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kalbe Farma may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
PFHOPacific Health Care 0.00 0 per month 4.11  0.07  12.17 (3.70) 43.80 
MYCOFMydecine Innovations Group 0.00 0 per month 0.00  0.02  0.00  0.00  170.08 
GLABFGemina Laboratories 0.00 0 per month 0.00 (0.08) 0.00 (27.54) 144.07 
QPTFFQuest PharmaTech 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
PPCBPropanc Biopharma Common 0.00 0 per month 0.00 (0.31) 7.89 (14.89) 58.21 
TELIFTelescope Innovations Corp 0.00 0 per month 5.33  0.02  13.04 (10.53) 69.65 
UEECUnited Health Products 0.00 0 per month 6.44  0.02  13.33 (12.50) 36.86 
LUFFFLuff Enterprises 0.00 0 per month 0.00  0.17  60.00 (11.76) 1,899 
SYGGFSynairgen plc 0.00 0 per month 0.00 (0.14) 0.00  0.00  50.00 
BTCYBiotricity(0.03)3 per month 0.00 (0.15) 11.76 (10.00) 29.57 

Other Forecasting Options for Kalbe Farma

For every potential investor in Kalbe, whether a beginner or expert, Kalbe Farma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kalbe Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kalbe. Basic forecasting techniques help filter out the noise by identifying Kalbe Farma's price trends.

Kalbe Farma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kalbe Farma pink sheet to make a market-neutral strategy. Peer analysis of Kalbe Farma could also be used in its relative valuation, which is a method of valuing Kalbe Farma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Kalbe Farma Market Strength Events

Market strength indicators help investors to evaluate how Kalbe Farma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kalbe Farma shares will generate the highest return on investment. By undertsting and applying Kalbe Farma pink sheet market strength indicators, traders can identify Kalbe Farma Tbk entry and exit signals to maximize returns.

Kalbe Farma Risk Indicators

The analysis of Kalbe Farma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kalbe Farma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kalbe pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Kalbe Farma

The number of cover stories for Kalbe Farma depends on current market conditions and Kalbe Farma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kalbe Farma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kalbe Farma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Additional Tools for Kalbe Pink Sheet Analysis

When running Kalbe Farma's price analysis, check to measure Kalbe Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalbe Farma is operating at the current time. Most of Kalbe Farma's value examination focuses on studying past and present price action to predict the probability of Kalbe Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalbe Farma's price. Additionally, you may evaluate how the addition of Kalbe Farma to your portfolios can decrease your overall portfolio volatility.